ProfileGDS4718 / 218693_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 90% 80% 87% 90% 80% 79% 87% 92% 90% 93% 88% 90% 87% 84% 88% 92% 82% 86% 79% 92% 90% 90% 90% 89% 79% 89% 72% 90% 86% 88% 86% 90% 91% 82% 84% 88% 87% 87% 76% 87% 80% 86% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7880487
GSM549102patient 115, normal, homogenized [OPG study]9.247890
GSM549104patient 119, normal, homogenized [OPG study]7.9386580
GSM549108patient 138, normal, homogenized [OPG study]8.713587
GSM549119patient 077, normal, homogenized [OPG study]9.2288690
GSM549133patient 032, cancer, homogenized [OPG study]7.9717780
GSM549139patient 042, cancer, homogenized [OPG study]7.7421679
GSM549099patient 107, normal, homogenized [OPG study]8.7060387
GSM549109patient 139, normal, homogenized [OPG study]9.6137392
GSM549110patient 046, normal, homogenized [OPG study]9.3153290
GSM549114patient 063, normal, homogenized [OPG study]9.9275393
GSM549122patient 082, normal, homogenized [OPG study]8.9240588
GSM549134patient 033, cancer, homogenized [OPG study]9.1701390
GSM549136patient 036, cancer, homogenized [OPG study]8.7508187
GSM549140patient 044, cancer, homogenized [OPG study]8.3967584
GSM549111patient 047, normal, homogenized [OPG study]8.913288
GSM549113patient 057, normal, homogenized [OPG study]9.7977792
GSM549132patient 031, cancer, homogenized [OPG study]8.1271682
GSM549137patient 038, cancer, homogenized [OPG study]8.6323986
GSM549142patient 047, cancer, homogenized [OPG study]7.5414179
GSM549100patient 110, normal, homogenized [OPG study]9.6145192
GSM549107patient 135, normal, homogenized [OPG study]9.3011590
GSM549115patient 068, normal, homogenized [OPG study]9.3715290
GSM549116patient 072, normal, homogenized [OPG study]9.2497190
GSM549120patient 078, normal, homogenized [OPG study]9.0666389
GSM549131patient 030, cancer, homogenized [OPG study]7.8273479
GSM549118patient 074, normal, homogenized [OPG study]9.0836689
GSM549129patient 027, cancer, homogenized [OPG study]7.0869372
GSM549123patient 088, normal, homogenized [OPG study]9.2738790
GSM549124patient 006, cancer, homogenized [OPG study]8.4987586
GSM549126patient 015, cancer, homogenized [OPG study]8.7990288
GSM549128patient 025, cancer, homogenized [OPG study]8.68686
GSM549103patient 117, normal, homogenized [OPG study]9.1264190
GSM549117patient 073, normal, homogenized [OPG study]9.5126891
GSM549138patient 041, cancer, homogenized [OPG study]8.1207382
GSM549141patient 045, cancer, homogenized [OPG study]8.4789184
GSM549130patient 028, cancer, homogenized [OPG study]8.7745688
GSM549101patient 111, normal, homogenized [OPG study]8.7341587
GSM549105patient 128, normal, homogenized [OPG study]8.7399787
GSM549106patient 134, normal, homogenized [OPG study]7.5264776
GSM549112patient 048, normal, homogenized [OPG study]8.8449787
GSM549125patient 011, cancer, homogenized [OPG study]7.8684380
GSM549127patient 024, cancer, homogenized [OPG study]8.5253986
GSM549135patient 035, cancer, homogenized [OPG study]8.9808888